In fact, ACE-2 is largely expressed in many cell types of the respiratory tract—the main route of virus entry to the body—as well as in the cardiovascular system, where additional important clinical manifestations of COVID-19 frequently occur [12,13,14,15]. This evidence concerns the gene ACE2 and COVID-19.